Cervical Intervertebral Disc Degeneration Clinical Trial
Official title:
A Prospective, Feasibility, Multi-Center Nonrandomized Clinical Trial Evaluating the Safety and Effectiveness of NuNec® Cervical Arthroplasty System
The objective of this study is to evaluate long-term safety and effectiveness of the NuNec® Cervical Arthroplasty System in a small patient population. The NuNec device is currently CE marked and commercially available in Europe.
The NuNec® feasibility study is a prospective, multi-centered, non-randomized clinical trial.
Only patients who have been diagnosed with single level, C3 to C7, symptomatic cervical
degenerative disc disease and have failed at least 6 weeks of conservative treatment or
present signs of progression of spinal cord/nerve root compression with continued
non-operative care will be enrolled.
Patients will be evaluated preoperatively and postoperatively at discharge, 6 weeks, 3, 6, 12
and 24 months.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00215293 -
Cervical I/F Cage for Anterior Cervical Fusion
|
Phase 3 |